Jiangxi Boya Bio-Pharmaceutical Co. Ltd. | Ownership
Companies that own Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
Chang'An International Trust Co. Ltd.
13,242,448
4.05%
13,242,448
4.38%
09/30/2017
China Universal Asset Management Co., Ltd.
7,399,963
2.27%
4,249,994
0.28%
09/30/2017
Fullgoal Fund Management Co., Ltd.
930,225
0.28%
-98,826
0.04%
12/31/2017
E Fund Management Co., Ltd.
914,132
0.28%
-743,800
0.03%
12/31/2017
The Vanguard Group, Inc.
568,500
0.17%
0
0%
07/31/2018
Guotai Junan Allianz Fund Management Co., Ltd.
466,850
0.14%
51,100
0.13%
12/31/2017
Guotai Asset Management Co., Ltd.
457,938
0.14%
-322,904
0.03%
12/31/2017
China Merchants Fund Management Co., Ltd.
280,861
0.09%
-22,050
0.03%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
280,750
0.09%
280,750
0.15%
12/31/2017
SWS MU Fund Management Co., Ltd.
192,133
0.06%
-26,750
0.03%
12/31/2017
| Address |
333 Huiquan Road
Fuzhou Jiangxi 344000
China
|
|
Employees
|
- |
| Website |
http://www.china-boya.com |
| Updated |
07/08/2019 |
| Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors. |
